Publications
Sort:
Open Access Issue
Clinical application of VV-A ECMO in lung transplantation
Journal of Nanjing Medical University (Natural Sciences) 2026, 46(11): 1691-1695
Published: 15 November 2026
Abstract PDF (5.3 MB) Collect
Downloads:0
Objective

To investigate the efficacy and advantages of the internal jugular-femoral-ascending aorta veno-venous-arterial extracorporeal membrane oxygenation (VV-A ECMO) mode in lung transplantation.

Methods

Clinical data of six high-risk lung transplant recipients (4 males, 2 females) who received intraoperative VV-A ECMO support between May 2025 and December 2025 were retrospectively analyzed, including general patient data, intraoperative cannulation strategy, changes of pulmonary artery pressure, blood loss, and postoperative ECMO mode conversion. All patients were evaluated as high-risk by a multidisciplinary team preoperatively.

Results

All six patients successfully underwent lung transplantation with VV-A ECMO support, maintained stable intraoperative respiration and circulation, and were weaned from ECMO postoperatively. One patient died of hemorrhagic shock on postoperative day 10. The remaining five patients survived to 30 days postoperatively and were discharged successfully.

Conclusion

The application of VV-A ECMO mode in lung transplantation provides effective respiratory and circulatory support, reduces surgical risk and offers favorable clinical value.

Open Access Review Issue
Microbiosis in lung allotransplantation and xenotransplantation: State of the art and future perspective
Health Care Science 2022, 1(2): 119-128
Published: 13 September 2022
Abstract PDF (1.2 MB) Collect
Downloads:83

The respiratory tract is known to harbor a microbial community including bacteria, viruses, and fungi. New techniques contribute enormously to the identification of unknown or culture‐independent species and reveal the interaction of the community with the host immune system. The existing respiratory microbiome and substantial equilibrium of the transplanted microbiome from donor lung grafts provide an extreme bloom of dynamic changes in the microenvironment in lung transplantation (LT) recipients. Dysbiosis in grafts are not only related to the modified microbial components but also involve the kinetics of the host‐graft “talk,” which signifies the destination of graft allograft injury, acute rejection, infection, and chronic allograft dysfunction development in short‐ and long‐term survival. Microbiome‐derived factors may contribute to lung xenograft survival when using genetically multimodified pig‐derived organs. Here, we review the most advanced knowledge of the dynamics and resilience of microbial communities in transplanted lungs with various pretransplant indications. Conceptual and analytical points of view have been illustrated along the time series, gaining insight into the microbiome and lung grafts. Future endeavors on precise tools, sophisticated models, and novel targeted regimens are needed to improve the long‐term survival in these patients.

Total 2